Antigenics Inc. facts

Antigenics Inc. is a biotechnology company founded in 1994 by Garo H. Armen and Pramod K. Srivastava. The company focuses on cancer vaccines, immunotherapeutics, adjuvants and infectious disease treatments. Antigenics became a public company in February 2000 on the NASDAQ exchange with the ticker symbol AGEN. In 2000 Antigenics acquired Aquila Biopharmaceuticals and in 2001 also acquired Aronex Pharmaceuticals. Antigenics has over 80 U.S. patents... more

Read article at Wikipedia

Date founded:

1994

Industry:

Biological Product (except Diagnostic) Manufacturing

Business

Address

Antigenics Inc. Headquarters

630 FIFTH AVENUE SUITE 2100

New York City New York 10111

United States of America

Revenue:

Currency	Amount	Valid Date
US$	700,000	Dec 31, 2006

Operating income:

Currency	Amount	Valid Date
US$	-44,210,000	Dec 31, 2006

Market capitalization:

Currency	Amount	Valid Date
US$	96,000,000	Dec 31, 2007

Board members:

View Antigenics Inc. board members »

Ticker symbol:

Stock exchange	Ticker symbol
NASDAQ	AGEN

Employees and other personnel:

Person	Title
Kerry Wentworth	Vice President
Garo H Armen	Chair
Garo H Armen	Chief Executive Officer
Shalini Sharp	Chief Financial Officer

View Antigenics Inc. employees and other personnel »

top ↑

Facts from the Community

From the BioVenturist base

Technology Focus:

Vaccine

Medical focus:

View entire collection »

From the business2 base

Revenue:

Currency	Amount	Valid Date
US$	2,650,000	Dec 31, 2008

Operating Income:

Currency	Amount	Valid Date
US$	-37,840,000	Dec 31, 2008

Net profit:

Currency	Amount	Valid Date
US$	-28,700,000	Dec 31, 2008

Cash:

Currency	Amount	Valid Date
US$	24,470,000	Dec 31, 2008

Current Assets:

Currency	Amount	Valid Date
US$	35,490,000	Dec 31, 2008

Total Assets:

Currency	Amount	Valid Date
US$	56,940,000	Dec 31, 2008

Current Liabilities:

Currency	Amount	Valid Date
US$	7,000,000	Dec 31, 2008

Total Liabilities:

Currency	Amount	Valid Date
US$	80,860,000	Dec 31, 2008

Retained Earnings:

Currency	Amount	Valid Date
US$	-527,340,000	Dec 31, 2008

top ↑

These people have edited this topic:

Metaweb Staff
jg
- Member Since: Nov 10, 2006
- Contributions: 336,758 Facts

Edit this topic

Last edited Dec 1, 2009 See all topic history »

Antigenics Inc.

Date founded:

Industry:

Business

Address

Antigenics Inc. Headquarters

Revenue:

Operating income:

Market capitalization:

Board members:

Ticker symbol:

Employees and other personnel:

Facts from the Community

From the BioVenturist base

Technology Focus:

Medical focus:

From the business2 base

Revenue:

Operating Income:

Net profit:

Cash:

Current Assets:

Total Assets:

Current Liabilities:

Total Liabilities:

Retained Earnings:

These people have edited this topic:

jg

Antigenics Inc. elsewhere on the web

What is Freebase?

Flag this Topic

Why do you want to flag this topic?

Antigenics Inc.

Date founded:

Industry:

Business

Address

Antigenics Inc. Headquarters

Revenue:

Operating income:

Market capitalization:

Board members:

Ticker symbol:

Employees and other personnel:

Facts from the Community

From the BioVenturist base

Technology Focus:

Medical focus:

From the business2 base

Revenue:

Operating Income:

Net profit:

Cash:

Current Assets:

Total Assets:

Current Liabilities:

Total Liabilities:

Retained Earnings:

These people have edited this topic:

jg

Related Topics

Antigenics Inc. elsewhere on the web

What is Freebase?

Flag this Topic

Why do you want to flag this topic?